ARTEMIS CAPITAL PARTNERS

Thesis

Artemis Capital Partners is a private equity firm headquartered in Boston, Massachusetts, specializing in acquiring and building differentiated manufacturers of industrial technologies. Their investment thesis centers on companies with strong fundamentals, solid management teams, and significant growth potential, particularly those in undervalued positions or poised for rapid expansion. The firm actively seeks majority and controlling interests in businesses that produce highly engineered, mission-critical products contributing to a healthier, safer, more connected, productive, and equitable world. Key investment sectors include Aerospace & Defense (components, C4ISR, UAS, autonomous platforms, cybersecurity, benefiting from European rearmament and NATO), Medical Devices and Life Sciences (laboratory automation, software, diagnostics, health & longevity), Semiconductor, and Industrial Technology (automation, software, controls, devices, sensors, instrumentation). Artemis primarily engages in buyout and growth equity investments, targeting companies with revenues between $5 million and $50 million and EBITDA of $1 million to $10 million. They also co-invest when necessary. As of December 31, 2025, AUM was approximately $441,542,162, with another filing in April 2025 indicating $293.6 million.

Related lists

• Series C+ investors based in Boston, MA